If you’re looking for information on Caralluma Fimbriata, then you’ve probably just read our Nucific Bio X4 review. C. Fimbriata is one of the primary ingredients in Bio X4. It is one of the ingredients which distinguishes Bio X4 from other probiotics. As those of you who have read our full review will know, Bio X4 is sold as a weight management supplement as well as a probiotic; it is the inclusion of C. Fimbriata and Green tea Extract which supposedly allows it to do both of these things at once.
But can Nucific’s claims hold water?
Does Caralluma Fimbriata really work?
Let’s take a look at the available scientific evidence to see whether or not this substance can actually do what it claims.
Clinical trials on C. Fimbriata
There have actually been relatively few studies done on C. Fimbriata, let alone many studies showing positive results.
The main study quoted in support of the use of caralluma fimrbiata as a weight loss aid is a trial published in Appetite in 2007. However, if you actually read this study, you’ll see that only 50 subjects were used, half of which were given a placebo. We are told nothing about how the different groups ate or exercised during the experiment. And to top it off, the researchers note that there was little difference between the “experimental group” (those given C. Fimbriata) and the placebo group in terms of weight lost, waist circumference, etc.
The study did find that C. Fimbriata was effective at suppressing appetite.
However, as already mentioned, the study group was very small. More importantly, their eating habits weren’t controlled for the duration of the study. We therefore can’t be certain whether the caralluma fimbriata was responsible for the reduced appetite, or other factors (e.g. fiber intake).
There are lots of supplements on the market today which claim to be appetite supressants. Caralluma fimbriata is one of many that are yet to be properly tested in robust, large scale clinical trials.
So does C. Fimbriata really work?
Not in our opinion. Until we see a clinical trial with more test subjects and a higher quality methodology, we’re not convinced!